From Krizzia Lavone Ramos Alferez, HAE Philippines

On September 8, 2025, the HAE symposium was conducted in Manila, Philippines, with participants including Anthony Castaldo—HAEi CEO and Advocacy Lead, Developing Southeast Asia; Krizzia Lavone Alferez—national contact; Dr. Philip Li; Dr. Jovilia Abong (HAE specialist in the Philippines); and BioCryst’s Dr. Dan Petroni and Lauren Mills. BioCryst is a pharmaceutical company with a pill that helps prevent HAE attacks.

The symposium was part of the annual convention of the Philippine Society of Allergy, Asthma, and Immunology (PSAAI) in cooperation with Dr. Joanne Mallillin and Dr. Kay Salvador-Tayag. 550 physicians from all across the Philippines were present.

Dr. Philip Li spoke on “Alliances and Advancements for Hereditary Angioedema in the Asia Pacific.” He also shared patient stories from Hong Kong and highlighted successful diagnostic and treatment progress.

Dr. Petroni chaired the symposium discussion, which covered the present situation and experiences of people with HAE in the Philippines. Numerous questions from attendees regarding the topic were raised. HAE Philippines is advocating for all Filipino patients and working to increase general awareness of the disease and win access to modern HAE medicines.